ClinicalTrials.gov
ClinicalTrials.gov Menu

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00981903
Recruitment Status : Terminated (Tinzaparin will no longer be available in the United States)
First Posted : September 22, 2009
Last Update Posted : July 6, 2017
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
University of Southern California

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2015